Galina Glazko
Concepts (281)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 15 | 2019 | 231 | 3.040 |
Why?
| Gene Expression Profiling | 15 | 2021 | 1119 | 2.100 |
Why?
| Gene Regulatory Networks | 7 | 2019 | 124 | 1.970 |
Why?
| Databases, Genetic | 8 | 2017 | 102 | 1.690 |
Why?
| Evolution, Molecular | 10 | 2012 | 110 | 1.660 |
Why?
| Transcriptome | 6 | 2021 | 344 | 1.580 |
Why?
| Colonic Neoplasms | 3 | 2019 | 167 | 1.400 |
Why?
| RNA | 4 | 2016 | 182 | 1.330 |
Why?
| Sequence Analysis, RNA | 6 | 2019 | 102 | 1.060 |
Why?
| Proteome | 3 | 2021 | 168 | 1.030 |
Why?
| Gene Expression | 6 | 2022 | 717 | 1.000 |
Why?
| Oligonucleotide Array Sequence Analysis | 10 | 2017 | 500 | 1.000 |
Why?
| Systems Biology | 2 | 2011 | 33 | 0.850 |
Why?
| Genes, Neoplasm | 1 | 2019 | 37 | 0.770 |
Why?
| Signal Transduction | 5 | 2019 | 1849 | 0.740 |
Why?
| Consensus | 1 | 2019 | 146 | 0.720 |
Why?
| Software | 3 | 2017 | 278 | 0.690 |
Why?
| Genes, p53 | 3 | 2013 | 64 | 0.680 |
Why?
| Phylogeny | 8 | 2010 | 268 | 0.670 |
Why?
| Colonic Polyps | 1 | 2017 | 46 | 0.660 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 201 | 0.650 |
Why?
| Models, Genetic | 7 | 2008 | 204 | 0.610 |
Why?
| Adenoma | 1 | 2017 | 149 | 0.600 |
Why?
| Genes, X-Linked | 1 | 2014 | 9 | 0.570 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2012 | 50 | 0.470 |
Why?
| Models, Statistical | 3 | 2012 | 268 | 0.460 |
Why?
| Tumor Suppressor Protein p53 | 3 | 2017 | 258 | 0.450 |
Why?
| Disease | 1 | 2011 | 28 | 0.440 |
Why?
| Azospirillum brasilense | 2 | 2022 | 4 | 0.430 |
Why?
| Genome, Viral | 3 | 2008 | 90 | 0.430 |
Why?
| Bacteriophages | 2 | 2007 | 11 | 0.430 |
Why?
| Phenotype | 5 | 2017 | 842 | 0.420 |
Why?
| Algorithms | 4 | 2017 | 737 | 0.380 |
Why?
| Humans | 30 | 2021 | 52937 | 0.370 |
Why?
| Principal Component Analysis | 2 | 2019 | 72 | 0.370 |
Why?
| Genome | 2 | 2007 | 69 | 0.350 |
Why?
| Computer Simulation | 4 | 2017 | 345 | 0.350 |
Why?
| Animals | 19 | 2021 | 14792 | 0.350 |
Why?
| Proteomics | 3 | 2021 | 326 | 0.340 |
Why?
| DNA | 3 | 2008 | 576 | 0.330 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 152 | 0.330 |
Why?
| Genetic Variation | 3 | 2009 | 261 | 0.320 |
Why?
| Chromosome Mapping | 2 | 2008 | 172 | 0.310 |
Why?
| Base Sequence | 7 | 2013 | 753 | 0.300 |
Why?
| Linkage Disequilibrium | 1 | 2005 | 51 | 0.300 |
Why?
| Molecular Sequence Data | 7 | 2012 | 1035 | 0.280 |
Why?
| Biological Evolution | 1 | 2005 | 42 | 0.280 |
Why?
| Gene Expression Regulation | 5 | 2017 | 1145 | 0.280 |
Why?
| Neoplasms | 2 | 2005 | 1254 | 0.270 |
Why?
| Multivariate Analysis | 3 | 2017 | 699 | 0.270 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 895 | 0.260 |
Why?
| Nuclear Matrix | 1 | 2003 | 3 | 0.250 |
Why?
| DNA, Intergenic | 1 | 2003 | 7 | 0.250 |
Why?
| Primates | 1 | 2003 | 23 | 0.250 |
Why?
| Conserved Sequence | 1 | 2003 | 59 | 0.250 |
Why?
| Proteins | 2 | 2014 | 404 | 0.240 |
Why?
| Herbaspirillum | 1 | 2022 | 2 | 0.240 |
Why?
| Cecum | 2 | 2021 | 75 | 0.240 |
Why?
| Genomics | 3 | 2017 | 268 | 0.240 |
Why?
| Cluster Analysis | 2 | 2017 | 264 | 0.230 |
Why?
| Cell Cycle Proteins | 2 | 2017 | 198 | 0.220 |
Why?
| Binding Sites | 3 | 2012 | 470 | 0.220 |
Why?
| Mutation | 4 | 2019 | 1427 | 0.220 |
Why?
| Cell Line, Tumor | 2 | 2017 | 1505 | 0.210 |
Why?
| Selection, Genetic | 3 | 2012 | 27 | 0.210 |
Why?
| Infant Formula | 1 | 2021 | 141 | 0.200 |
Why?
| RNA, Untranslated | 1 | 2019 | 15 | 0.200 |
Why?
| Sequence Alignment | 4 | 2007 | 156 | 0.190 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2013 | 58 | 0.190 |
Why?
| Ruminococcus | 1 | 2019 | 9 | 0.190 |
Why?
| Extracellular Matrix | 1 | 2019 | 121 | 0.180 |
Why?
| Reproducibility of Results | 3 | 2016 | 1330 | 0.180 |
Why?
| Phosphoproteins | 2 | 2013 | 121 | 0.180 |
Why?
| RNA, Messenger | 3 | 2019 | 1275 | 0.180 |
Why?
| Starch | 1 | 2019 | 33 | 0.180 |
Why?
| Profilins | 1 | 2018 | 21 | 0.180 |
Why?
| Sample Size | 2 | 2015 | 46 | 0.180 |
Why?
| Pharmacogenetics | 1 | 2018 | 53 | 0.170 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 41 | 0.170 |
Why?
| Small Molecule Libraries | 1 | 2018 | 74 | 0.170 |
Why?
| Hyperplasia | 1 | 2017 | 120 | 0.170 |
Why?
| Neurodegenerative Diseases | 1 | 2018 | 80 | 0.170 |
Why?
| GTP-Binding Proteins | 1 | 2017 | 92 | 0.170 |
Why?
| Chromatin | 2 | 2012 | 150 | 0.170 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 84 | 0.170 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 100 | 0.160 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 147 | 0.160 |
Why?
| Lampreys | 2 | 2007 | 2 | 0.160 |
Why?
| DNA Replication | 2 | 2016 | 150 | 0.160 |
Why?
| Diet | 1 | 2021 | 612 | 0.160 |
Why?
| Data Mining | 1 | 2017 | 37 | 0.160 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 134 | 0.160 |
Why?
| Colorectal Neoplasms | 1 | 2019 | 234 | 0.160 |
Why?
| Protein Interaction Maps | 1 | 2016 | 24 | 0.150 |
Why?
| Down-Regulation | 1 | 2017 | 402 | 0.150 |
Why?
| Protein Processing, Post-Translational | 1 | 2017 | 185 | 0.150 |
Why?
| Protein Interaction Mapping | 1 | 2016 | 47 | 0.150 |
Why?
| Models, Theoretical | 1 | 2017 | 200 | 0.150 |
Why?
| Sequence Analysis, DNA | 2 | 2007 | 283 | 0.150 |
Why?
| Up-Regulation | 1 | 2017 | 538 | 0.150 |
Why?
| Mice | 5 | 2020 | 6401 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2017 | 386 | 0.140 |
Why?
| Kidney | 1 | 2020 | 834 | 0.140 |
Why?
| Germ-Line Mutation | 2 | 2005 | 66 | 0.140 |
Why?
| Breast Neoplasms | 3 | 2021 | 1274 | 0.130 |
Why?
| DNA Helicases | 1 | 2016 | 142 | 0.130 |
Why?
| Bacterial Proteins | 1 | 2019 | 472 | 0.130 |
Why?
| Likelihood Functions | 2 | 2005 | 63 | 0.130 |
Why?
| Lung Neoplasms | 1 | 2019 | 598 | 0.130 |
Why?
| Data Interpretation, Statistical | 2 | 2013 | 185 | 0.130 |
Why?
| Lymphocytes | 1 | 2014 | 174 | 0.130 |
Why?
| Activating Transcription Factor 1 | 1 | 2013 | 23 | 0.130 |
Why?
| RNA Stability | 1 | 2013 | 26 | 0.130 |
Why?
| Nuclear Proteins | 2 | 2006 | 272 | 0.130 |
Why?
| RNA, Fungal | 1 | 2013 | 29 | 0.120 |
Why?
| Schizosaccharomyces pombe Proteins | 1 | 2013 | 38 | 0.120 |
Why?
| RNA, Antisense | 1 | 2012 | 10 | 0.120 |
Why?
| Schizosaccharomyces | 1 | 2013 | 55 | 0.120 |
Why?
| RNA, Double-Stranded | 1 | 2012 | 17 | 0.120 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 10 | 0.120 |
Why?
| Drosophila melanogaster | 1 | 2012 | 22 | 0.120 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 138 | 0.120 |
Why?
| Ribosomal Proteins | 1 | 2012 | 30 | 0.120 |
Why?
| Tunica Intima | 1 | 2012 | 65 | 0.120 |
Why?
| Carotid Arteries | 1 | 2012 | 91 | 0.120 |
Why?
| Chromosome Disorders | 1 | 2012 | 40 | 0.120 |
Why?
| Disease Progression | 3 | 2020 | 899 | 0.110 |
Why?
| Amino Acid Sequence | 4 | 2008 | 807 | 0.110 |
Why?
| Adaptation, Physiological | 1 | 2012 | 102 | 0.110 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 167 | 0.110 |
Why?
| Protein Array Analysis | 1 | 2010 | 27 | 0.110 |
Why?
| Rats | 3 | 2019 | 3593 | 0.110 |
Why?
| Gene Transfer, Horizontal | 2 | 2007 | 9 | 0.110 |
Why?
| Plant Roots | 2 | 2022 | 39 | 0.110 |
Why?
| Ethanol | 1 | 2012 | 331 | 0.100 |
Why?
| Chromosomes | 1 | 2008 | 37 | 0.090 |
Why?
| Periodicity | 1 | 2008 | 34 | 0.090 |
Why?
| Bacteria | 2 | 2021 | 238 | 0.090 |
Why?
| Thermus thermophilus | 1 | 2008 | 1 | 0.090 |
Why?
| Siphoviridae | 1 | 2008 | 1 | 0.090 |
Why?
| Bayes Theorem | 2 | 2012 | 124 | 0.090 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2008 | 103 | 0.090 |
Why?
| Viral Proteins | 2 | 2008 | 169 | 0.090 |
Why?
| Cell Proliferation | 1 | 2012 | 1128 | 0.090 |
Why?
| Cytosine Deaminase | 1 | 2007 | 5 | 0.080 |
Why?
| Receptors, Antigen | 1 | 2007 | 2 | 0.080 |
Why?
| Flow Cytometry | 1 | 2010 | 583 | 0.080 |
Why?
| Aryldialkylphosphatase | 1 | 2007 | 4 | 0.080 |
Why?
| DNA, Viral | 1 | 2008 | 152 | 0.080 |
Why?
| Amino Acid Substitution | 2 | 2004 | 111 | 0.080 |
Why?
| Nuclear Envelope | 1 | 2006 | 5 | 0.080 |
Why?
| Male | 7 | 2020 | 28317 | 0.080 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2007 | 83 | 0.080 |
Why?
| Adaptation, Biological | 1 | 2005 | 10 | 0.080 |
Why?
| Receptors, Immunologic | 1 | 2005 | 38 | 0.070 |
Why?
| Immunity | 1 | 2005 | 40 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2011 | 457 | 0.070 |
Why?
| Pan troglodytes | 1 | 2005 | 14 | 0.070 |
Why?
| Fossils | 1 | 2005 | 18 | 0.070 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 59 | 0.070 |
Why?
| Hominidae | 1 | 2005 | 16 | 0.070 |
Why?
| Saccharomyces cerevisiae | 1 | 2006 | 197 | 0.070 |
Why?
| Calibration | 1 | 2005 | 59 | 0.070 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 162 | 0.070 |
Why?
| Mutation, Missense | 1 | 2005 | 117 | 0.070 |
Why?
| Gene Expression Regulation, Archaeal | 1 | 2004 | 2 | 0.070 |
Why?
| DNA, Neoplasm | 1 | 2005 | 178 | 0.070 |
Why?
| Genes, Archaeal | 1 | 2004 | 4 | 0.070 |
Why?
| Species Specificity | 1 | 2005 | 225 | 0.070 |
Why?
| Chickens | 1 | 2005 | 123 | 0.070 |
Why?
| Eukaryotic Cells | 1 | 2004 | 17 | 0.070 |
Why?
| Genes | 1 | 2004 | 38 | 0.070 |
Why?
| Genes, Fungal | 1 | 2004 | 38 | 0.070 |
Why?
| Inheritance Patterns | 1 | 2004 | 24 | 0.070 |
Why?
| Genes, Bacterial | 1 | 2004 | 75 | 0.070 |
Why?
| Statistics as Topic | 1 | 2004 | 108 | 0.070 |
Why?
| CpG Islands | 1 | 2004 | 104 | 0.070 |
Why?
| Genes, Tumor Suppressor | 1 | 2004 | 87 | 0.070 |
Why?
| Quality Control | 1 | 2004 | 98 | 0.070 |
Why?
| Membrane Proteins | 1 | 2006 | 390 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2007 | 570 | 0.060 |
Why?
| DNA Topoisomerases, Type I | 1 | 2003 | 4 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2004 | 146 | 0.060 |
Why?
| Time | 1 | 2003 | 33 | 0.060 |
Why?
| DNA Topoisomerases, Type II | 1 | 2003 | 16 | 0.060 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2003 | 61 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2020 | 1699 | 0.060 |
Why?
| Trans-Activators | 1 | 2004 | 162 | 0.060 |
Why?
| DNA Transposable Elements | 1 | 2003 | 96 | 0.060 |
Why?
| Genome, Bacterial | 1 | 2004 | 151 | 0.060 |
Why?
| Immunoglobulins | 1 | 2003 | 88 | 0.060 |
Why?
| Myocardial Infarction | 1 | 2007 | 468 | 0.060 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2004 | 252 | 0.060 |
Why?
| Female | 4 | 2021 | 28945 | 0.050 |
Why?
| DNA-Binding Proteins | 1 | 2004 | 512 | 0.050 |
Why?
| Models, Animal | 1 | 2021 | 267 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 50 | 0.050 |
Why?
| Nucleic Acid Conformation | 2 | 2013 | 100 | 0.050 |
Why?
| Milk, Human | 1 | 2021 | 105 | 0.050 |
Why?
| Animals, Newborn | 1 | 2021 | 400 | 0.050 |
Why?
| Swine | 1 | 2021 | 436 | 0.050 |
Why?
| Transcription Factors | 1 | 2004 | 639 | 0.050 |
Why?
| Decision Trees | 1 | 2019 | 28 | 0.050 |
Why?
| RNA, Plant | 1 | 2019 | 7 | 0.050 |
Why?
| Genes, Plant | 1 | 2019 | 11 | 0.050 |
Why?
| Symbiosis | 1 | 2019 | 9 | 0.050 |
Why?
| Gene Expression Regulation, Plant | 1 | 2019 | 37 | 0.050 |
Why?
| Motor Neurons | 1 | 2018 | 39 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 167 | 0.040 |
Why?
| Neuroglia | 1 | 2018 | 51 | 0.040 |
Why?
| Cell Cycle | 2 | 2012 | 280 | 0.040 |
Why?
| Spinal Cord | 1 | 2018 | 161 | 0.040 |
Why?
| Protein Isoforms | 1 | 2017 | 139 | 0.040 |
Why?
| Time Factors | 1 | 2005 | 3440 | 0.040 |
Why?
| Mice, Transgenic | 1 | 2018 | 729 | 0.040 |
Why?
| Phosphorylation | 1 | 2017 | 643 | 0.040 |
Why?
| MicroRNAs | 1 | 2019 | 366 | 0.040 |
Why?
| Prognosis | 1 | 2021 | 2105 | 0.040 |
Why?
| Databases, Factual | 1 | 2018 | 698 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 869 | 0.030 |
Why?
| DNA Repair | 1 | 2016 | 217 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2019 | 1809 | 0.030 |
Why?
| Cell Line | 1 | 2017 | 1226 | 0.030 |
Why?
| Research Design | 1 | 2016 | 369 | 0.030 |
Why?
| Tunica Media | 1 | 2012 | 10 | 0.030 |
Why?
| S Phase | 1 | 2012 | 20 | 0.030 |
Why?
| G1 Phase | 1 | 2012 | 19 | 0.030 |
Why?
| Lod Score | 1 | 2012 | 7 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 85 | 0.030 |
Why?
| Genes, Insect | 1 | 2012 | 12 | 0.030 |
Why?
| Larva | 1 | 2012 | 23 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 32 | 0.030 |
Why?
| Microarray Analysis | 1 | 2012 | 85 | 0.030 |
Why?
| Open Reading Frames | 1 | 2012 | 59 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 211 | 0.030 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 104 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2012 | 147 | 0.030 |
Why?
| Internet | 1 | 2012 | 302 | 0.020 |
Why?
| Prostatic Neoplasms | 1 | 2013 | 412 | 0.020 |
Why?
| Virion | 1 | 2008 | 20 | 0.020 |
Why?
| Glioma | 1 | 2008 | 72 | 0.020 |
Why?
| Breast | 1 | 2008 | 93 | 0.020 |
Why?
| Cells, Cultured | 1 | 2012 | 1840 | 0.020 |
Why?
| DNA, Complementary | 1 | 2008 | 150 | 0.020 |
Why?
| Recombination, Genetic | 1 | 2008 | 114 | 0.020 |
Why?
| Aspartic Acid | 1 | 2007 | 48 | 0.020 |
Why?
| Age of Onset | 1 | 2007 | 121 | 0.020 |
Why?
| Centrosome | 1 | 2006 | 12 | 0.020 |
Why?
| Chromosome Segregation | 1 | 2006 | 12 | 0.020 |
Why?
| Glutamic Acid | 1 | 2007 | 113 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2006 | 193 | 0.020 |
Why?
| Spores, Bacterial | 1 | 2005 | 12 | 0.020 |
Why?
| Bacillus anthracis | 1 | 2005 | 11 | 0.020 |
Why?
| Bacillus subtilis | 1 | 2005 | 17 | 0.020 |
Why?
| Glutamine | 1 | 2007 | 171 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 303 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2005 | 71 | 0.020 |
Why?
| Arginine | 1 | 2007 | 188 | 0.020 |
Why?
| Brain Neoplasms | 1 | 2008 | 252 | 0.020 |
Why?
| Genotype | 1 | 2007 | 637 | 0.020 |
Why?
| Protein Binding | 1 | 2006 | 786 | 0.020 |
Why?
| Locus Control Region | 1 | 2003 | 1 | 0.020 |
Why?
| Globins | 1 | 2003 | 14 | 0.020 |
Why?
| Terminal Repeat Sequences | 1 | 2003 | 7 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2007 | 582 | 0.020 |
Why?
| 5' Untranslated Regions | 1 | 2003 | 35 | 0.020 |
Why?
| Mammals | 1 | 2002 | 50 | 0.020 |
Why?
| False Positive Reactions | 1 | 2002 | 71 | 0.020 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2003 | 104 | 0.020 |
Why?
| Plants | 1 | 2002 | 52 | 0.010 |
Why?
| Genome, Human | 1 | 2003 | 130 | 0.010 |
Why?
| Cohort Studies | 1 | 2007 | 1539 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 2451 | 0.010 |
Why?
| Prospective Studies | 1 | 2007 | 2452 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
| Brain | 1 | 2008 | 1466 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2007 | 3636 | 0.010 |
Why?
| Risk Factors | 1 | 2007 | 4005 | 0.010 |
Why?
| Aged | 1 | 2007 | 10453 | 0.010 |
Why?
| Middle Aged | 1 | 2007 | 13660 | 0.010 |
Why?
| Adult | 1 | 2007 | 14365 | 0.010 |
Why?
|
|
Glazko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|